Adaptogenics Health (ADPT.CN) Stock Price

Adaptogenics Health Price

CLOSED
0.30
​
Market closed

Adaptogenics Health's net margin stands at -74,800.0%, down from -13,363.6% several years earlier.

Adaptogenics Health stock price

Access this data via the Eulerpool API

Adaptogenics Health business model & stock analysis

Adaptogenics Health Corp. engages in the formulation and distribution of functional mushroom products and nutritional supplement alternatives. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2023-01-09. The firm is focused on the formulation and distribution of functional mushroom products and nutritional supplement alternatives. The company creates product formulations combining functional mushrooms and their adaptogens, which supports holistic health. The firm intends to launch five mushroom liquid tonics, including Reishi, Chaga, Turkey Tail, Lions Mane and Cordyceps (Cultured Chinese Caterpillar Fungus). The firm sells its products directly to consumers through Website as well as wholesaling to retailers throughout Canada.

Frequently asked questions about Adaptogenics Health

Converted at the current exchange rate, the Adaptogenics Health share trades at 0.19 EUR (0.30 CAD).

The revenue cannot currently be calculated for Adaptogenics Health.

The profit cannot currently be calculated for Adaptogenics Health.

The P/E ratio cannot be calculated for Adaptogenics Health at the moment.

The P/S cannot be calculated for Adaptogenics Health currently.

The Eulerpool Quality Score for Adaptogenics Health is 3/10.

The ISIN of Adaptogenics Health is CA00654R1091. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Adaptogenics Health is ADPT.CN. The ticker symbol is used to trade Adaptogenics Health shares on the stock exchange.

Fair ValueTerminal
0.25 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Country
Currency
CAD
Initial public offering
Jan 9, 2023
ISIN
CA00654R1091
Cusip
00654R109
Market capitalization
4.51 M CADMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
78.21
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-129.64 %
Last updated Oct 10, 2026, 11:42 PM

Adaptogenics Health Peer Group

Adaptogenics Health FIGI

ADPT:CN · BBG01C8VQW06ADPT:CF · BBG01C8VQW60ADPT:TG · BBG01C8VQWG9ADPT:TW · BBG01C8VQWJ6ADPT:DG · BBG01C8VQWQ8ADPT:QF · BBG01C8VQWR7ADPT:QH · BBG01C8VQWS6ADPT:TO · BBG01C8VQWW1ADPT:DL · BBG01C8VQWX0ADPT:DM · BBG01C8VQWY9ADPT:DN · BBG01C8VQWZ8ADPT:QG · BBG01C8VQX04